Log in to save to my catalogue

Exploring the views of infection consultants in England on a novel delinked funding model for antimi...

Exploring the views of infection consultants in England on a novel delinked funding model for antimi...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10391702

Exploring the views of infection consultants in England on a novel delinked funding model for antimicrobials: the SMASH study

Publication information

Publisher

US: Oxford University Press

More information

Scope and Contents

Contents

Abstract
Objectives
A novel ‘subscription-type’ funding model was launched in England in July 2022 for ceftazidime/avibactam and cefiderocol. We explored the views of infection consultants on important aspects of the delinked antimicrobial funding model.
Methods
An online survey was sent to all infection consultants in NHS acute hospita...

Alternative Titles

Full title

Exploring the views of infection consultants in England on a novel delinked funding model for antimicrobials: the SMASH study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10391702

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10391702

Other Identifiers

ISSN

2632-1823

E-ISSN

2632-1823

DOI

10.1093/jacamr/dlad091

How to access this item